<DOC>
	<DOC>NCT00701831</DOC>
	<brief_summary>Primary objective: - To observe the efficacy of the forced titration to reach good glycemic control in Lantus treated patients Secondary objectives: - To assess the forced titration on physician and patient satisfaction - To evaluate the impact of training tools by means of patient profile</brief_summary>
	<brief_title>Assessment of Insulin Glargine in Type 2 Patients for Good Glycemic Control</brief_title>
	<detailed_description />
	<mesh_term>Diabetes Mellitus</mesh_term>
	<mesh_term>Diabetes Mellitus, Type 2</mesh_term>
	<mesh_term>Insulin, Globin Zinc</mesh_term>
	<mesh_term>Insulin</mesh_term>
	<mesh_term>Insulin Glargine</mesh_term>
	<criteria>T2 insulin na√Øve patients Patients whom their physician is considering initiation of Lantus treatment Poor glycemic control 7,5 %10 % T2 treatment with OADs more than 3 months BMI&lt;40 kg/m2 Impaired renal function (Cr&gt;2mg/dl or current renal dialysis) Acute or chronic metabolic acidosis Active liver disease or serum ALT or AST &gt;2,5 than normal History of hypoglycemia unawareness Diabetic retinopathy with surgery in the previous 3 months or planned within 3 months after study entry Pregnancy, breast feeding The above information is not intended to contain all considerations relevant to a patient's potential participation in a clinical trial.</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>